The Third U.S. Circuit Court of Appeals has breathed new life into a False Claims Act (FCA) lawsuit against a New Jersey hospice provider. The provider has been contending with whistleblowers for some time now, who allege violations of the FCA related to Medicare reimbursements for ineligible patients.
Cases around Medicare reimbursement often hinge on specific patient documentation. This lawsuit is no exception. According to the provision of the Medicare program, to be eligible for hospice care coverage, the law necessitates that patient’s physician must certify that the patient is expected to live six months or less, should the illness proceed along a normal course. Furthermore, this prediction of terminal illness must be underpinned by solid clinical evidence. The crux of this dispute resides in the patients whose documentation apparently did not substantiate their eligibility for hospice services.
While the case continues, it represents an ongoing shift in the legal realm addressing Medicare fraud and abuse, particularly surrounding hospice care. It underscores the importance for healthcare providers to ensure meticulous, irrefutable documentation is compiled to evidence patient eligibility for Medicare-funded services. This legal action is a reminder that negligence in maintaining accurate documentation can open healthcare providers to allegations of FCA violations.
As the battle against fraudulent Medicare claims continues, healthcare providers and law firms must strive to stay abreast of developments, including court decisions and new regulations to effectively navigate the changing legal landscape. To read more about this ongoing case, you can visit Arnall Golden Gregory LLP’s analysis of the situation.